Maternal Health Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Maternal Health Market is Segmented By Treatment (Hormones, Nutritives, Analgesics, Anti-Infectives, Others), By Indication (Miscarriage, Premature Labor and Birth, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023 - 2030

Maternal Health Market Overview

The Global Maternal Health Market reached US$ 14.1 billion in 2022 and is expected to reach US$ 28.3 billion by 2030 growing with a CAGR of 8.5% during the forecast period 2023-2030. 

The maternal health market is driven by factors such as increasing awareness and education, rising maternal age, government initiatives, growing healthcare infrastructure and awareness of maternal mental health. 

Regular medical check-ups, screenings, and testing are part of proper prenatal care during pregnancy. The health of the mother and the growing fetus is ensured through early detection and treatment of any potential issues. The health of the mother and the unborn child depends on eating a good and balanced diet. The growth and development of the fetus are supported by an adequate intake of necessary nutrients, which also protects the mother's health.

Maternal Health Market Scope and Summary

For more details on this report – Request for Sample

Maternal Health Market Dynamics and Trends

The Increasing Collaboration Among Key Players is Driving the Global Maternal Health Market Growth

In May 2023, in order to commercialize distinctive and ground-breaking products in the areas of Maternal Health & Urology, CORONA Remedies Private Limited (CORONA) entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of global biopharmaceuticals company Ferring Pharmaceuticals with headquarters in Switzerland.

The partnership between CORONA and Ferring will provide patients all over India with cutting-edge products, some of which will be from international brands, to meet the unmet treatment requirements in urology and maternal health. They are thrilled to collaborate with Ferring, a research-driven, specialty biopharmaceutical group, to provide patients in India with top-notch medications.

The Increasing Funding for Maternal Health Boost The Global Maternal Health Market Growth

In January 2023, The Christian Medical College (CMC) in Vellore, Tamil Nadu, now has an advanced simulation lab center due to the U.S. Agency for International Development (USAID).  The lab will be used to train medical professionals in maternal and neonatal care, including CPR, basic and advanced nursing techniques, and the newest technologies to address maternal health and newborn emergencies.  

The American Schools and Hospitals Abroad (ASHA) program of USAID provides a $1 million (USD) grant to fund the Advanced Simulation Lab Center.  ASHA works to create friendly and mutually beneficial relationships between Americans and Indians.  Since patient safety, protocols, and debriefing methods are crucial for student evaluation and feedback, the institution adopts American best practices in these areas.  Modern supplies and equipment for the hospital's neonatal critical care unit and labor and delivery rooms were also made possible by USAID through this effort.  

Challenges with Maternal Health are Hampering the Global Maternal Health Market Growth

There are discrepancies in access to high-quality healthcare services in many areas, especially for underserved people, which has a negative impact on maternal health outcomes. Poor prenatal care can stem from a lack of knowledge and understanding about proper maternal health care, which could cause issues throughout pregnancy and childbirth. For many women, particularly in low-income or uninsured populations, the expense of high-quality maternal health services, including prenatal care, delivery, and postnatal care, can be prohibitive.  

Market Segment Analysis

The global maternal health market is segmented based on treatment, indication, distribution channel, and region.

The Hormones Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The hormones segment accounted for the highest market stake accounting for approximately 45.4% of the maternal health market in 2022. Hormones and maternal health are tightly related during pregnancy and the postpartum period. The different physiological and mental changes that take place in a woman's body during pregnancy and after childbirth are significantly regulated by hormones.

For the mother's and the fetus's health to be maintained during pregnancy, specific hormones must be produced in greater quantities. The most notable hormones involved in pregnancy are progesterone, estrogen, human chorionic gonadotropin hormone (hCG), and human placental lactogen (hPL). A hormone called progesterone is essential for preserving the uterine lining and avoiding contractions. Progesterone supplements may occasionally be advised for women who have a history of recurrent miscarriages or who have a short cervix.  

Maternal Health Market Geographical Penetration

North America Holds a Dominant Position in the Global Maternal Health Market

North America is estimated to hold around 1/3rd of the total market share throughout the forecast period. In October 2022, The Special Supplemental Nutrition Program for Women, Infants, and Children, or WIC, has undergone significant modernization and innovation, and the U.S. Department of Agriculture recognizes its accomplishment and promise. The American Rescue Plan Act of 2021 has provided funding for three significant awards totaling about $53 million, as part of the efforts. 

Together, these investments will increase the number of eligible women and young children that WIC reaches, improve the level of care that they get throughout their involvement with the program, and assist to close long-standing gaps in maternal and child health. 

Maternal Health Market Companies and Competitive Landscape

The major global players in the market include Johnson & Johnson, Jiovio Healthcare, Pfizer Inc., GlaxoSmithKline Inc., Merck & Co., Inc., RAND Corporation, SYNAPSE Product Development, Siemens, Reckitt Benckiser Group Plc, Sanofi among others.

COVID-19 Impact on Maternal Health Market

The COVID-19 epidemic has increased the number of patients admitted to emergency departments and intensive care units. Patients suffering from severe infections typically have respiratory failure or low oxygen saturation, necessitating the use of positive air pressure devices such as ventilators. As a result, demand for airway control devices, particularly single-use devices, is increasing. As non-invasive methods carry the potential of virus particle aerosolization, the number of patients requiring intubation via invasive airway management procedures has grown. Healthcare practitioners that provide airway management treatment to COVID-19 patients and other patients in healthcare institutions are putting themselves at danger, which has boosted the demand for single-use devices. 

Russia-Ukraine Conflict Analysis

The Russia-Ukraine war may affect the maternal health market due to a lack of facilities being impacted during times of geopolitical instability and economic uncertainty. It may be challenging for expectant mothers to get adequate prenatal and postnatal care if healthcare facilities are damaged or destroyed as a result of the conflict. Conflict zones' hospitals and clinics may be overburdened or unable to deliver proper care. 

Artificial Intelligence Analysis:

Artificial intelligence (AI) is increasingly being used in the maternal health market to improve various aspects of data analysis. A pregnant woman's medical history, health information, and lifestyle choices can be analyzed by AI algorithms to identify potential risk factors and forecast difficulties during pregnancy. This enables medical practitioners to develop individualized care regimens and intervene early.

Pregnant women can remotely monitor their health due to wearable technology and mobile apps that are powered by AI. These gadgets can monitor fetal movements, contraction patterns, and other pertinent information, alerting medical professionals if any unsettling trends are found.

Key Developments

• In March 2023, MedArrive, the top mobile-integrated care management solution, announced a partnership with Ouma Health, a provider of whole maternity telehealth services, in order to provide complete maternal-fetal care to at-risk women on Medicaid. By including a crucial service into MedArrive's expanding ecosystem of specialized care providers that managed Medicaid health plans can utilize for members in their homes, the collaboration intends to improve the health of expectant mothers and their newborns, particularly those at high risk.

Why Purchase the Report?

• To visualize the global maternal health market segmentation based on the treatment, indication, distribution channel, and region and understand key commercial assets and players. 
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of maternal health market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of critical products of all the major players.

The global maternal health market report would provide approximately 61 tables, 57 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies